Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HDAC6: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
Cytoplasmic deacetylase critical for protein quality control, aggresome formation, and autophagy in neurodegenerative diseases
No AI portrait yet
| Gene Symbol | HDAC6 |
| Full Name | Histone Deacetylase 6 |
| Chromosome | Xp11.23 |
| Protein Type | Protein |
| Function | is a unique class IIb histone deacetylase that predominantly localizes to the cytoplasm rather than the nucleus. |
| Primary Expression | Ubiquitous, highest in brain, liver, kidney |
| Molecular Weight | 131 kDa |
| Amino Acids | 1215 aa |
| Pathways | AUTOPHAGY, Amyloid, Autophagy, Dna Repair, Inflammasome |
| UniProt ID | Q9UQR8 |
| NCBI Gene ID | 10013 |
| Ensembl ID | ENSG00000094631 |
| GeneCards | HDAC6 |
| Human Protein Atlas | HDAC6 |
| Associated Diseases | Als, Alzheimer's disease, Amyotrophic Lateral Sclerosis, Cancer, Cardiovascular, Diabetes |
| Known Drugs/Compounds | curcumin, lithium, Ramalin, rapamycin |
| Interactions | ACAT1, ACTB, Actin, ADCY3, AGING, AGO2 |
| SciDEX Hypotheses | HDAC6 Inhibition for Charcot-Marie-Tooth Disease a HDAC6 Selective Inhibition to Restore Acetylation HDAC6 Inhibition for Dual Restoration of Microtubu (+1 more) |
| KG Connections | 1123 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
flowchart TD
HDAC6(["HDAC6"])
Autophagic_Degradation("Autophagic Degradation")
P62(["P62"])
PROTEASOME["PROTEASOME"]
Alzheimer["Alzheimer"]
Als["Als"]
Cancer["Cancer"]
OPTN(["OPTN"])
Autophagy["Autophagy"]
OXIDATIVE_STRESS(["OXIDATIVE STRESS"])
UBIQUITIN(["UBIQUITIN"])
Tumor["Tumor"]
Parkinson["Parkinson"]
HDAC6 -->|"regulates"| Autophagic_Degradation
P62 -->|"modulates"| HDAC6
PROTEASOME -->|"modulates"| HDAC6
HDAC6 -->|"regulates"| Alzheimer
HDAC6 -->|"regulates"| Als
HDAC6 -->|"regulates"| Cancer
HDAC6 -->|"activates"| Als
HDAC6 -->|"therapeutic target"| Als
HDAC6 -->|"interacts with"| OPTN
HDAC6 -->|"activates"| Autophagy
HDAC6 -->|"regulates"| OXIDATIVE_STRESS
HDAC6 -->|"activates"| UBIQUITIN
HDAC6 -->|"associated with"| Tumor
HDAC6 -->|"associated with"| Parkinson
HDAC6 -->|"associated with"| Cancer
style HDAC6 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| HDAC6 | encodes | protein | 0.00 |
| Macroautophagy | involved_in | process | 0.95 |
| Autophagosome-Lysosome Fusion | regulates | process | 0.90 |
| neurons | expressed_in | cell_type | 0.90 |
| CTTN | regulates | gene | 0.90 |
| Autophagosome-Lysosome Fusion | promotes | process | 0.90 |
| neurodegeneration | inhibits | disease | 0.90 |
| alpha-tubulin acetylation | inhibits | process | 0.90 |
| Lewy Bodies | component_of | structure | 0.90 |
| Tubulin Acetylation | catalyzes | process | 0.85 |
| Proteasomal Inhibition | mediates | mechanism | 0.85 |
| Synaptic Failure | contributes_to | process | 0.85 |
| acetylation | inhibits | process | 0.85 |
| Protein Aggregates | degrades | structure | 0.85 |
| Parkinson Disease | associated_with | disease | 0.85 |
| Memory Restoration | targets | phenotype | 0.82 |
| neural stem cells | activates | cell_type | 0.80 |
| neural stem cells | regulates | cell_type | 0.80 |
| neuroinflammation | inhibits | disease | 0.80 |
| neuroinflammation | regulates | disease | 0.80 |
| F-actin cytoskeleton | regulates | pathway | 0.80 |
| Multiple System Atrophy | associated_with | disease | 0.80 |
| P62 | interacts_with | protein | 0.80 |
| epigenetic regulation | participates_in | pathway | 0.80 |
| PIK3C3 | regulates | gene | 0.80 |
| NLRP3 inflammasome | activates | protein | 0.80 |
| Als | regulates | disease | 0.75 |
| Alzheimer | regulates | disease | 0.75 |
| TAU | associated_with | protein | 0.75 |
| Als | activates | disease | 0.75 |
| Α-Tubulin | modulates | protein | 0.75 |
| Cancer | regulates | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Alzheimer's disease | associated_with | disease | 0.70 |
| Alzheimer's disease | inhibits | disease | 0.70 |
| STROKE | inhibits | disease | 0.70 |
| apoptosis pathway | participates_in | pathway | 0.70 |
| Parkinson's disease | activates | disease | 0.70 |
| Parkinson's disease | regulates | disease | 0.70 |
| Autophagy | activates | pathway | 0.70 |
| neurodegeneration | regulates | disease | 0.70 |
| OXIDATIVE STRESS | regulates | gene | 0.70 |
| ULK1 | regulates | gene | 0.70 |
| TFEB | regulates | gene | 0.70 |
| SQSTM1 | regulates | gene | 0.70 |
| AMPK signaling | participates_in | pathway | 0.70 |
| UBIQUITIN | activates | gene | 0.70 |
| OPTN | interacts_with | protein | 0.70 |
| MAP1LC3B | regulates | gene | 0.70 |
| MTOR | regulates | gene | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HDAC6 | encodes | gene | 0.00 |
| ISG15 | inhibits | gene | 0.95 |
| ISG15 | binds | gene | 0.90 |
| SGK1 | upregulates | gene | 0.90 |
| h-ca454967 | targets_gene | hypothesis | 0.90 |
| PIK3C3 | phosphorylates | protein | 0.80 |
| BACE1 | interacts_with | gene | 0.80 |
| Ramalin | inhibits | gene | 0.70 |
| BACE1 | activates | gene | 0.70 |
| rapamycin | targets | drug | 0.70 |
| ATG | regulates | gene | 0.70 |
| AR | activates | gene | 0.70 |
| ATG | activates | gene | 0.70 |
| BDNF | co_discussed | gene | 0.65 |
| BACE1 | co_discussed | gene | 0.65 |
| MAPT | inhibits | gene | 0.65 |
| NEK1 | causes | gene | 0.65 |
| HIPPOCAMPUS | inhibits | brain_region | 0.65 |
| MAPT | treats | gene | 0.65 |
| NEURODEGENERATION | inhibits | disease | 0.65 |
| STK11 | associated_with | gene | 0.60 |
| HSPA8 | associated_with | gene | 0.60 |
| CALCOCO2 | associated_with | gene | 0.60 |
| STX17 | associated_with | gene | 0.60 |
| RB1CC1 | associated_with | gene | 0.60 |
| TUBB3 | associated_with | gene | 0.60 |
| CDC42 | regulates | gene | 0.60 |
| ULK1 | associated_with | gene | 0.60 |
| KAT5 | associated_with | gene | 0.60 |
| KAT2B | associated_with | gene | 0.60 |
| OPTN | associated_with | gene | 0.60 |
| WIPI2 | associated_with | gene | 0.60 |
| BECN1 | associated_with | gene | 0.60 |
| BCL2 | associated_with | gene | 0.60 |
| RAB9A | associated_with | gene | 0.60 |
| BCL2L1 | associated_with | gene | 0.60 |
| GLA | associated_with | gene | 0.60 |
| GABARAP | associated_with | gene | 0.60 |
| PSEN2 | associated_with | gene | 0.60 |
| CTSD | associated_with | gene | 0.60 |
| FYCO1 | associated_with | gene | 0.60 |
| SQSTM1 | associated_with | gene | 0.60 |
| RB1 | associated_with | gene | 0.60 |
| SNAP29 | associated_with | gene | 0.60 |
| NRF2 | contributes_to | gene | 0.60 |
| BECN1 | regulates | gene | 0.60 |
| CASP3 | regulates | gene | 0.60 |
| PIK3C3 | associated_with | gene | 0.60 |
| MAP1LC3B | associated_with | gene | 0.60 |
| OCLN | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| HDAC6 Inhibition for Charcot-Marie-Tooth Disease and ALS | 0.793 | neurodegeneration | Test |
| HDAC6 Activation as SCFA-Mediated Neuroprotective Mechanism | 0.682 | neurodegeneration | Do SCFAs directly modulate α-synuclein a |
| HDAC6 Selective Inhibition to Restore Acetylation Balance an | 0.643 | structural-biology | What is the atomic-resolution structure |
| Brain-Ester Prodrug Strategy for CNS-Selective HDAC6 Inhibit | 0.570 | pharmacology | How can CNS-selective HDAC/DNMT inhibito |
| HDAC6 Inhibition for Dual Restoration of Microtubule Stabili | 0.484 | neurodegeneration | Which tau PTMs are both disease-specific |
| HDAC6 Inhibitor Therapy for Pan-Neurodegenerative Protein Ho | 0.450 | neurodegeneration | Comparative epigenetic signatures across |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-16 | 7 hypotheses Top: 0.550
neurodegeneration | 2026-04-15 | 2 hypotheses Top: 0.634
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.484
structural biology | 2026-04-13 | 1 hypotheses Top: 0.643
structural biology | 2026-04-10 | 0 hypotheses
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.72 · 2026-04-21
closed · Rounds: 4 · Score: 0.30 · 2026-04-21
closed · Rounds: 4 · Score: 0.50 · 2026-04-18
closed · Rounds: 4 · Score: 0.68 · 2026-04-15
closed · Rounds: 4 · Score: 0.86 · 2026-04-14
closed · Rounds: 4 · Score: 0.74 · 2026-04-14
closed · Rounds: 4 · Score: 0.65 · 2026-04-13
closed · Rounds: 4 · Score: 0.87 · 2026-04-02
Hypotheses and analyses mentioning HDAC6 in their description or question text